Quantcast

Latest Spinal muscular atrophy Stories

2011-07-25 23:27:04

Spinal muscular atrophy (SMA) is the most frequently inherited cause of infant mortality. Two independent research groups "” one led by Alex MacKenzie, at Children's Hospital of Eastern Ontario Research Institute, Ottawa; and one led by Umrao R. Monani, at Columbia University Medical Center, New York, and Cathleen M. Lutz, at The Jackson Laboratory, Bar Harbor "” have now generated new data in mouse models of severe SMA that provide hope that a therapeutic providing meaningful...

2011-06-06 14:00:00

Failure in nerve-fiber navigation corrected in zebrafish model; suggests possibility of a drug treatment BOSTON, June 6, 2011 /PRNewswire-USNewswire/ -- Spinal muscular atrophy (SMA) is the leading genetic cause of death in children under 2, with no treatment other than supportive care. In the Proceedings of the National Academy of Sciences (Early Edition, week of June 6), researchers at Children's Hospital Boston show how loss or mutation of the SMA gene causes progressive muscle...

2011-05-19 07:37:00

First ever clinical trial approved for SMA with a novel drug specifically designed to treat the disease CHICAGO, May 19, 2011 /PRNewswire-USNewswire/ -- Families of Spinal Muscular Atrophy announced today that Repligen Corporation has received approval from the U.S. Food and Drug Administration to commence a Phase I safety study in healthy volunteers for RG3039, formerly called Quinazoline495, which is being developed for Spinal Muscular Atrophy. FSMA began the Quinazoline program in...

2011-05-04 09:48:00

WASHINGTON, May 4, 2011 /PRNewswire/ -- The 2011 FightSMA Annual Conference, the Good Fight, is underway at the L'Enfant Plaza Hotel this week, and experts in the fields of pulmonology, nutrition, orthopedics, clinical trial and neurology are gearing up to participate in the Thriving with SMA: LIVE! webcast on Thursday, May 5, 2011. This one-of-a-kind, unique web-based program is free to the public and will feature panel discussions by leaders in the SMA community. Online attendees and...

2011-04-29 15:22:00

WASHINGTON, April 29, 2011 /PRNewswire/ -- International non-profit organization FightSMA will be hosting highly respected experts from across the country on Thursday, May 5, 2011 for a series of panel discussions, Thriving with SMA: LIVE! This panel is a unique, one-of-a-kind series of presentations from influential leaders in the fields of pulmonary issues, orthopedics, nutrition, neurology and clinical trial. FightSMA will be joined by families, friends, healthcare professionals and...

2011-04-28 14:47:00

WASHINGTON, April 28, 2011 /PRNewswire/ -- FightSMA will be welcoming elite researchers and scientific professionals, as well as families and friends in the SMA community, to the L'Enfant Plaza Hotel May 3-6, 2011 in Washington, D.C. The group, which was founded in 1991, is celebrating its 20th anniversary this year. To date, FightSMA has raised more than $7 million for SMA research and boasts 19 chapters in the U.S. and Canada. The centerpiece of the Conference will be the Thriving with...

2011-02-24 05:00:00

MADISON, N.J., Feb. 24, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it has signed a definitive agreement to acquire Athena Diagnostics, an esoteric laboratory specializing in genetic testing for neurological disorders, from Thermo Fisher Scientific (NYSE: TMO) for $740 million in cash. Athena Diagnostics is the leading provider of advanced diagnostic tests used to rule...

2011-02-23 00:00:41

International nonprofit FightSMA is celebrating the beginning of it 20th year of fighting spinal muscular atrophy (SMA) by launching a completely redesigned website. Richmond, VA (PRWEB) February 21, 2011 Parents fighting spinal muscular atrophy (SMA), the leading genetic killer of children under two, need help and information. Recognizing that need, FightSMA, an international nonprofit organization dedicated to finding a cure for SMA, is announcing the launch of its all new website,...

2011-02-09 15:02:26

New research using a mouse model of the motor neuron disease spinal muscular atrophy (SMA) reveals an abnormality in the way that sensory information is relayed to motor neurons in the spinal cord. Importantly, this disruption in communication occurs very early in disease progression and precedes the neuronal death and muscle weakness that are the hallmark of the disease. The study, published by Cell Press in the February 10 issue of the journal Neuron, suggests that therapeutic strategies...

2011-01-19 08:00:00

NEW YORK and AUSTIN, Texas, Jan. 19, 2011 /PRNewswire/ -- The Spinal Muscular Atrophy (SMA) Foundation and Rules-Based Medicine, Inc. (RBM) announced today that they have reached the first milestone in a program to develop a panel of plasma protein biomarkers for SMA using RBM's Multi-Analyte Profiling (MAP) technology platform. In this collaboration, RBM will discover and also confirm plasma protein biomarker candidates previously identified from the multicenter Biomarkers for SMA...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.